Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Repurposing low-dose naltrexone for the prevention and treatment of immunothrombosis in COVID-19
Bertram Pitt, Ashley M. Tate, David Gluck, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2022) Vol. 8, Iss. 4, pp. 402-405
Open Access | Times Cited: 19

Showing 19 citing articles:

Long COVID: major findings, mechanisms and recommendations
Hannah Davis, Lisa McCorkell, Julia Moore Vogel, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 3, pp. 133-146
Open Access | Times Cited: 2592
Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative
Hector Bonilla, Michael J. Peluso, Kathleen E. Rodgers, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 58
The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID
Jingwei Li, Yun Zhou, Jiechao Ma, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 57
Pathophysiological mechanisms of thrombosis in acute and long COVID-19
Haijiao Jing, Xiaoming Wu, Mengqi Xiang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 49
Low-dose naltrexone and NAD+ for the treatment of patients with persistent fatigue symptoms after COVID-19
Anar Isman, Andy Nyquist, Bailey Strecker, et al.
Brain Behavior & Immunity - Health (2024) Vol. 36, pp. 100733-100733
Open Access | Times Cited: 12
Molecular cross-talk between long COVID-19 and Alzheimer’s disease
Magdalena Pszczołowska, Kamil Walczak, Weronika Miśków, et al.
GeroScience (2024) Vol. 46, Iss. 3, pp. 2885-2899
Open Access | Times Cited: 7
GPCR drug discovery: new agents, targets and indications
José A. Lorente, Aleksandr V. Sokolov, Gavin Ferguson, et al.
Nature Reviews Drug Discovery (2025)
Closed Access
Endogenous opiates and behavior: 2022
Richard J. Bodnar
Peptides (2023) Vol. 169, pp. 171095-171095
Closed Access | Times Cited: 11
An update on Long COVID
Gary Grohmann, Robert Booy
Microbiology Australia (2024)
Open Access | Times Cited: 2
Expert guidance on the management and challenges of long-COVID syndrome: a systematic review
Josuel Ora, Luigino Calzetta, Chiara Frugoni, et al.
Expert Opinion on Pharmacotherapy (2022) Vol. 24, Iss. 3, pp. 315-330
Closed Access | Times Cited: 11
COVID‐19 vaccine adverse events: Evaluating the pathophysiology with an emphasis on sulfur metabolism and endotheliopathy
Heidi N. du Preez, Johnson Lin, Glenn E. M. Maguire, et al.
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 10
Open Access | Times Cited: 1
Low-dose naltrexone reduced anxiety in persons with multiple sclerosis during the COVID-19 pandemic
Patricia J. McLaughlin, Laura Odom, Peter A. Arnett, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109438-109438
Open Access | Times Cited: 5
Long-term impact of COVID-19 on the cardiovascular system
Carme Pérez-Quilis, Fabián Sanchis‐Gomar, François Haddad, et al.
Elsevier eBooks (2024), pp. 77-96
Closed Access
Hemostasis correction in the treatment and rehabilitation of COVID-19 patients
К. N. Grigoreva, N. R. Gashimova, В. И. Цибизова
Реабилитология. (2024) Vol. 1, Iss. 1, pp. 49-59
Closed Access
Effectiveness of Treatments for Long Vax: Protocol for a Prospective Cohort Study (Preprint)
Matthew Halma
(2024)
Closed Access
Expanding the scope of mast cell disease: Does mast cell‐derived TNF play a role in immune‐mediated chronic illness and autoimmunity?
Rachel Gorman, Iffath Unissa Syed
Rheumatology & autoimmunity (2024) Vol. 4, Iss. 4, pp. 218-225
Open Access
A Review of Factors Influencing Anxiety and Depression in Persons with Multiple Sclerosis during the COVID-19 Pandemic
Patricia J. McLaughlin, Laura Odom, Ian S. Zagon
Medical Research Archives (2023) Vol. 11, Iss. 6
Open Access
Long COVID Syndrome: Clinical Presentation, Pathophysiology, Management
Yoon Jeong Cho, Dae Hyun Kim
Gyemyeong uidae haksulji (2023) Vol. 42, Iss. 2, pp. 71-74
Open Access
Pharmacological treatment of CVD
Stefan Agewall
European Heart Journal - Cardiovascular Pharmacotherapy (2022) Vol. 9, Iss. 1, pp. 1-3
Open Access
Page 1

Scroll to top